Health Encyclopedia

 

Health Encyclopedia Home



Despite Major Progress, Some Childhood Cancers Are Still Killers

Despite Major Progress, Some Childhood Cancers Are Still Killers

THURSDAY, Nov. 7 (HealthDay News) -- Recent decades have seen huge strides in treating childhood cancer, but certain types of tumors remain difficult to treat and are often deadly.

That's the frustrating fact at the heart of a meeting held this week by the American Association for Cancer Research. Pediatric cancer experts gathered in San Diego to discuss recent advances in understanding childhood tumors and the obstacles to improving kids' care.

"The exciting thing is that we're in an era of unprecedented discovery," said Dr. John Maris, referring to recent research on the genetic underpinnings of childhood cancers. "But there's still a huge amount of work to be done."

One of the challenges in pediatric cancer research is that, thankfully, it's relatively rare for children to develop cancer, said Maris, who directs the Center for Childhood Cancer Research at Children's Hospital of Philadelphia.

In the United States, one or two out of every 10,000 kids develop cancer each year, according to the U.S. National Cancer Institute. It amounts to around 12,000 cases of childhood cancer and about 1,500 deaths annually.

Dr. James Downing, deputy director of St. Jude Children's Research Hospital in Memphis, Tenn., said that's a very small amount compared with the number of adults diagnosed with cancer.

As a result, Downing said, government funds and drug companies' interests are largely focused on adult cancer.

"There are also very important practical considerations, because these are children," Maris said.

Drugs of any kind typically are tested first in adults to help shield kids from toxic effects of experimental therapies. Safety concerns, plus limited resources and other issues, can slow progress.

"In pediatrics, we have to be very, very careful about prioritizing what we test," Maris said.

In some cancer areas, there have been huge success stories. A major example is the blood cancer acute lymphoblastic leukemia (ALL), the most common type of cancer in children. In the early 1960s, only about 4 percent of U.S. children diagnosed with ALL were alive five years later. Now that number exceeds 90 percent.

Overall, the five-year survival rate from all childhood cancers combined has risen from around 60 percent in the mid-1970s to more than 80 percent in more recent years, according to the cancer institute.

Downing said, however, that cancer still kills more kids under age 15 than any other disease. And certain types remain stubbornly resistant to everything doctors have thrown at them.

"There's a subset of cancers where we just have not made progress," Maris said.

One example is a tumor of the brain stem called pontine glioma -- a "terrible disease," Downing said, that usually kills within a year.

Another example is neuroblastoma, a cancer of the nerve tissue in various parts of the body that usually arises before age 5. Many more kids survive the disease than in years past, but the chances depend in part on the child's age.

Infants have a high cure rate, with about 90 percent alive five years later; that dips to 68 percent among children diagnosed between the ages of 1 and 4, according to the cancer institute.

The biology of a child's neuroblastoma is also key. "We used to think all neuroblastomas were the same," Maris said. "They're not."

Maris and his colleagues found that mutations in a gene called ALK are behind a rare form of neuroblastoma that runs in families.

An oral cancer drug -- already tested and approved for certain cases of lung cancer in adults -- targets ALK. In early trials, the drug, called crizotinib, led to remission in kids with the rare form of neuroblastoma and children with an uncommon, aggressive type of lymphoma.

At St. Jude, Downing and his colleagues have been working on a project to "decode" the genomes of more than 600 children with cancer in an attempt to gain a better understanding of the genetic origins of various tumors. They've found specific gene mutations in certain gliomas, neuroblastomas and rare subtypes of leukemia that they hope will someday lead to better treatments.

But even with highly curable cancers, such as ALL, safer treatments are needed. The chemotherapy, radiation and other therapies used to battle kids' cancer can have unfortunate side effects years later -- including other cancers and heart and lung damage.

"When you're talking about children, a cure is not enough," Maris said.

Both Maris and Downing pointed to better funding as a vital need. "We need advocacy at the legislative level to make sure pediatric cancers aren't unwittingly discriminated against," Maris said.

Public support -- including donations to foundations supporting pediatric cancer research -- can also help, Downing said. "This can't get done without support from the general public," he said.

More information

The National Cancer Institute has more on childhood cancer.

SOURCES: James Downing, M.D., deputy director, St. Jude Children's Research Hospital, Memphis, Tenn.; John Maris, M.D., director, Center for Childhood Cancer Research, Children's Hospital of Philadelphia; American Association for Cancer Research, Nov. 6, 2013, news release

 
Related Items
Content Type 134
  Metastatic Brain Tumors
  Gliomas
  Meningioma
  Basics of Brain Tumors
Drug Reference
  Lomustine, CCNU
  Vincristine
  Temozolomide
  Carmustine, BCNU
Cancer Source
  Statistics About Brain Tumors
  Am I At Risk for a Brain Tumor?
  Targeted Therapy for Brain Tumors
  What Are the Symptoms of a Brain Tumor?
  Types of Brain Tumors
  I've Just Been Told I Have a Brain Tumor
  Support for a Loved One with a Brain Tumor
  Understanding Your Grade of Brain Tumor
  Types of Treatment for Brain Tumors
  What to Know About Surgery for Brain Tumors
  What to Know About Chemotherapy for Brain Tumors
  What to Know About Radiation Therapy for Brain Tumors
  Rehabilitation for Children with Brain Tumors
  Do What You Can to Ease Side Effects of Treatment for a Brain Tumor
  Coping with the Cognitive Effects of Brain Tumors
  Tests that Help Evaluate a Brain Tumor
  Tips for People With Brain Tumors
  Tell Your Health Care Team How You Feel During Treatment for a Brain Tumor
  What Are the Survival Rates for People With Brain Tumors?
Cancer FAQs
  Frequently Asked Questions About Brain Tumor
Daily News Feed
  Channel Blockers for Blood Pressure Linked to Breast Cancer Risk, Study Finds
  Antiviral Drug May Extend Brain Cancer Survival, Researchers Say
  Report Sees Continued Advances in War Against Cancer
  Scientists 'Silence' Aggressive Brain Cancer Gene in Mice
  Childhood Cancer Report Brings Mixed News
  Avastin Shows Mixed Results Against Different Cancers
  Tumor-Targeting Agent Attaches to Cancer Cells: Study
Adult Diseases and Conditions
  Brain Tumors
Pediatric Diseases and Conditions
  Brain Tumors in Children